Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice

Clinical and Experimental Pharmacology and Physiology

Volumn 28, Issue 10, 2001, Pages 809-815

  Kondo, Yukiko ^a   Toda, Yoshihisa ^a   Kitajima, Hideaki ^a   Oda, Hiroaki ^b   Nagate, Takatoshi ^a   Kameo, Kazuya ^a   Murakami, Shigeru ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Anti oxidant; Apolipoprotein E deficient mice; Atherosclerosis; Taurine

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERY LESION; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFECT; GENE DELETION; HISTOLOGY; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; STAINING; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; AORTIC VALVE; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0034773911     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2001.03527.x     Document Type: Article

References (42)

1. Taurine: Biological update
2. Physiological actions of taurine
3. Pathogenesis and dietary prevention of cardiovascular diseases in animal models and epidemiological evidence for the applicability in man
4. Biochemistry and physiology of taurine and taurine derivatives
5. Effect of taurine, glycine and β-sitosterol on serum and tissue cholesterol in the rat and rabbit
6. Effect of methionine, cysteine, and taurine on plasma cholesterol level in rats fed a high-cholesterol diet
7. Stimulation of chenodeoxycholic acid excretion in hypercholesterolemic mice by dietary taurine
8. Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats
9. Taurine accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats
10. Restoration of endothelium-dependent relaxation in both hypercholesterolemia and diabetes by chronic taurine
11. Dietary taurine decreases hepatic secretion of cholesterol ester in rats fed a high-cholesterol diet
12. The effects of taurine on atherosclerosis development in cholesterol-fed rabbits
13. Improvement of cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet
14. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
15. Spontaneous hyper-cholesterolemia and arterial lesions in mice lacking apolipoprotein E
16. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
17. A simple fluorometric assay for lipoperoxide in blood plasma
18. Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system
19. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A
20. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice
21. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
22. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
23. The pathogenesis of atherosclerosis: A perspective for the 1990s
24. Role of oxidized low density lipoprotein in atherogenesis
25. Antioxidants and atherosclerotic heart disease
26. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits
27. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
28. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susuceptibility of LDL to oxidation and aggregation
29. Effect of viatmin E on atherogenesis in LDL receptor-deficient rabbits
30. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
31. Probucol decreases neo-intimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis
32. Effect of probucol on xanthomata regression in familial hypercholesterolemia
33. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice. Possible mechanisms of action
34. ApoE deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
35. Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice
36. The effects of taurine on perfused heart muscle malondialdehyde levels
37. Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardinal revascularization
38. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats
39. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice
40. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice
41. The angiotensin-converting enzyme inhibitor, fosinopril, and angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice
42. Lipoprotein binding to canine hepatic membranes. Metabolicaly distinc apo-E and apo-B,E receptors